BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3528556)

  • 1. [Pathogenic factors in mixed infection due to Bacteroides fragilis and other species of bacteria in mice].
    Miyazaki S; Ishii T; Tsuji A; Kitaya S; Kaneko Y; Ogawa M; Goto S
    Nihon Saikingaku Zasshi; 1986 May; 41(3):611-7. PubMed ID: 3528556
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenic synergy between Escherichia coli and Bacteroides fragilis or B. vulgatus in experimental infections: a non-specific phenomenon.
    Verweij-van Vught AM; Namavar F; Vel WA; Sparrius M; MacLaren DM
    J Med Microbiol; 1986 Feb; 21(1):43-7. PubMed ID: 3512833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superoxide dismutase in Bacteroides fragilis and related Bacteroides species.
    Carlsson J; Wrethén J; Beckman G
    J Clin Microbiol; 1977 Sep; 6(3):280-4. PubMed ID: 332713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic synergy between Escherichia coli and Bacteroides fragilis: studies in an experimental mouse model.
    Verweij-van Vught AM; Namavar F; Sparrius M; Vel WA; MacLaren DM
    J Med Microbiol; 1985 Jun; 19(3):325-31. PubMed ID: 3892009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On some factors involved in virulence of Bacteroides fragilis.
    Munteanu V; Bittner J; Rău C
    Arch Roum Pathol Exp Microbiol; 1982; 41(1):15-25. PubMed ID: 7052015
    [No Abstract]   [Full Text] [Related]  

  • 6. Wound infection: a controlled clinical and experimental demonstration of synergy between aerobic (Escherichia coli) and anaerobic (Bacteroides fragilis) bacteria.
    Kelly MJ
    Ann R Coll Surg Engl; 1980 Jan; 62(1):52-9. PubMed ID: 6987938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between polymorphonuclear leucocytes, Bacteroides sp, and Escherichia coli: their role in the pathogenesis of mixed infection.
    Vel WA; Namavar F; Verweij-van Vught AM; Pubben AN; MacLaren DM
    J Clin Pathol; 1986 Apr; 39(4):376-82. PubMed ID: 3517072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
    Rotstein OD; Kao J
    Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous injection of mice with bacteroides fragilis and Escherichia coli: role of Thioglycollate medium in the infectious process.
    Rodloff AC; Rodloff S; Fischer B; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 May; 254(3):405-12. PubMed ID: 6372324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenicity of the Bacteroides fragilis group.
    Brook I
    Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis.
    Rotstein OD; Pruett TL; Simmons RL
    Arch Surg; 1985 Feb; 120(2):146-51. PubMed ID: 3156575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide dismutase and O2 lethality in Bacteroides fragilis.
    Privalle CT; Gregory EM
    J Bacteriol; 1979 Apr; 138(1):139-45. PubMed ID: 438129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD; Kao J; Houston K
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of Bacteroides fragilis group from clinical specimens following antimicrobial therapy.
    Brook I; Frazier EH
    Can J Microbiol; 1992 Mar; 38(3):226-9. PubMed ID: 1393825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of the liver and biliary tract to anaerobic infection in extrahepatic biliary tract obstruction. III. Possible synergistic effect between anaerobic and aerobic bacteria. An experimental study in rabbits.
    Lykkegaard Nielsen M; Asnaes S; Justesen T
    Scand J Gastroenterol; 1976; 11(3):263-72. PubMed ID: 775613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenicity of Bacteroides fragilis and related species estimated by intracutaneous infection in the guinea-pig.
    Maskell JP
    J Med Microbiol; 1981 Feb; 14(1):131-40. PubMed ID: 7463462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerobic and anaerobic bacterial interactions in the development of anaerobic bacterial pneumonia.
    Goto J
    Kansenshogaku Zasshi; 1992 Dec; 66(12):1660-9. PubMed ID: 1294672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bacterial association on virulence of Entamoeba histolytica to baby hamster kidney cell monolayers.
    Ghosh PK; Gupta S; Naik S; Ayyagari A; Naik SR
    Indian J Exp Biol; 1998 Sep; 36(9):911-5. PubMed ID: 9854433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.
    Onderdonk AB; Kasper DL; Cisneros RL; Bartlett JG
    J Infect Dis; 1977 Jul; 136(1):82-9. PubMed ID: 886206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.